Sze-Piaw Chin (Sze Piaw Chin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Preterm Infants

Mesenchymal Stem Cells

Top Venues

In vitro cellular & developmental biology. Animal

Regenerative medicine

Stem cells international

This page only lists publications with an associated author ORCID identifier.

Publications

Sze-Piaw Chin, Nik Syazana Saffery, Kong-Yong Then, Soon-Keng Cheong
Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In vitro cellular & developmental biology. Animal 60 (3) (2024)
Sze-Piaw Chin, Nik Syazana Saffery, Kong-Yong Then, Soon-Keng Cheong
Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In vitro cellular & developmental biology. Animal (2024)
Sze-Piaw Chin, Nik Syazana Saffery, Kong-Yong Then, Soon-Keng Cheong
Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In vitro cellular & developmental biology. Animal 60 (3) (2024)
Sze-Piaw Chin, Nik Syazana Saffery, Kong-Yong Then, Soon-Keng Cheong
Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In vitro cellular & developmental biology. Animal 60 (3) (2024)
Sze-Piaw Chin, Nik Syazana Saffery, Kong-Yong Then, Soon-Keng Cheong
Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In vitro cellular & developmental biology. Animal 60 (3) (2024)
Lihui Tai, Nik Syazana Saffery, Sze-Piaw Chin, Soon Keng Cheong
Secretome profile of TNF-α-induced human umbilical cord mesenchymal stem cells unveils biological processes relevant to skin wound healing. Regenerative medicine (2023)
Sze-Piaw Chin, Mohd-Yusoff Mohd-Shahrizal, Mohd-Zuhar Liyana, Kong Yong Then, Soon Keng Cheong
High Dose of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (CLV-100) Infusion Displays Better Immunomodulatory Effect among Healthy Volunteers: A Phase 1 Clinical Study. Stem cells international 2020 (2020)